Principia Biopharma Inc. Common Stock
PRNB
PRNB was delisted on the 25th of September, 2020.
9 hedge funds and large institutions have $6.05M invested in Principia Biopharma Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 131 closing their positions.
123% more call options, than puts
Call options by funds: $1.85M | Put options by funds: $830K
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
93% less funds holding
Funds holding: 137 → 9 (-128)
98% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 131
100% less capital invested
Capital invested by funds: $1.91B → $6.05M (-$1.9B)
100% less funds holding in top 10
Funds holding in top 10: 6 → 0 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
+$1.87M |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$1.45M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$278K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$2.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$296M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$162M |
| 3 |
BlackRock
New York
|
-$158M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$114M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$95.1M |
PRNB Hedge Fund Activity: Q3 2020 in Review
9 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Principia Biopharma Inc. Common Stock (PRNB) for Q3 2020, worth a combined $6.05M — down 100% from $1.91B a quarter earlier.
Sellers outnumbered buyers: 131 funds closed out of PRNB and 3 opened new positions — a net loss of 128 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Ohio Public Employees Retirement System (OPERS), opening a new position worth an estimated $1.87M. The largest seller was Fidelity Investments, exiting entirely with an estimated $296M sold.
- 9 institutional investors held Principia Biopharma Inc. Common Stock (PRNB) as of Q3 2020, down from 137 in Q2 2020.
- Funds reported $6.05M of Principia Biopharma Inc. Common Stock stock for Q3 2020, down 100% quarter-over-quarter.
- 3 funds opened new Principia Biopharma Inc. Common Stock positions in Q3 2020 and 131 closed out, a net change of -128 holders.
- The largest Principia Biopharma Inc. Common Stock buyer in Q3 2020 was Ohio Public Employees Retirement System (OPERS), an estimated $1.87M added.
- The largest Principia Biopharma Inc. Common Stock seller in Q3 2020 was Fidelity Investments, an estimated $296M sold.
Based on aggregated 13F filings for Q3 2020.